Opportunity Information: Apply for PA 10 115
Apply for PA 10 115
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Indo U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.856 Microbiology and Infectious Diseases Research.
- This funding opportunity was created on Apr 3, 2013 and posted on Feb 26, 2010.
- Applicants must submit their applications by Apr 3, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments Private institutions of higher education County governments Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Public and State controlled institutions of higher education Small businesses Special district governments Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled Additional Information on Eligibility for clarification) Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Indo U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03) is a National Institutes of Health (NIH) discretionary grant opportunity designed to strengthen and expand long-standing vaccine research collaboration between the United States and India. The program traces back to a formal Memorandum of Understanding signed on July 9, 1987, created to build on earlier bilateral science and technology cooperation frameworks such as the Indo-U.S. Science and Technology Subcommission, the Gandhi-Reagan Science and Technology Initiative, the U.S.-India Fund, and the broader Science and Technology Cooperation Agreement. At its core, the VAP aims to support joint vaccine-related research that can ultimately reduce the burden of infectious diseases that matter to India, the U.S., the South Asian region, and global public health.
This specific funding announcement (Funding Opportunity Number PA 10-115) uses the NIH R03 mechanism, which is intended for small, focused research projects. The grant provides U.S. dollar support for vaccine-related research activities carried out in India and the United States and is meant to augment ongoing VAP efforts rather than operate as a standalone clinical trial funding stream. The scientific scope is targeted: applicants are encouraged to propose projects in dengue, influenza (including avian influenza), HIV/AIDS, and tuberculosis, provided the work is conducted through well-established collaborations with Indian investigators. The program is open to a range of vaccine research approaches, including basic research (early-stage discovery and immunology), translational work (bridging lab findings toward product-relevant concepts), clinical research that does not involve trials, and epidemiological studies that inform vaccine development or evaluation strategies. A key limitation is that clinical trials are explicitly not supported under this initiative, meaning proposals should avoid trial implementation and instead focus on preparatory, supporting, or non-trial clinical and population research.
Eligibility is broad and includes many types of U.S. and non-U.S. entities, reflecting the collaborative and international nature of the program. Eligible applicants include state, county, city, township, and special district governments; public and state-controlled universities; private institutions of higher education; nonprofit organizations with or without 501(c)(3) status; public housing authorities and Indian housing authorities; for-profit organizations (excluding small businesses in the listed category, though small businesses are also explicitly eligible); independent school districts; and a variety of tribal governments and tribal organizations. The eligibility list also explicitly mentions Alaska Native and Native Hawaiian Serving Institutions, Historically Black Colleges and Universities (HBCUs), Hispanic Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), faith-based and community-based organizations, regional organizations, U.S. territories or possessions, and non-domestic (non-U.S.) entities/foreign organizations. Cost sharing or matching is not required, which lowers barriers for applicants who might otherwise need to bring outside funds to participate.
Funding levels and the anticipated number of awards are not fixed because NIH expects applications to vary widely in scope, duration, and cost. As a result, the total dollars awarded and the number of grants made depend on the quantity and quality of submissions, the proposed timelines, and budget reasonableness. The program is categorized under Health and is associated with CFDA 93.856 (Microbiology and Infectious Diseases Research). Key dates in the listing show it was posted February 26, 2010, with later administrative dates indicating it ultimately became archived after the final closing window in 2013. For applicants or institutions seeking more detail, NIH provided the full announcement link (http://grants.nih.gov/grants/guide/pa-files/PA-10-115.html) and directed technical access questions to the NIH Office of Extramural Research (OER) webmaster.
FAQs: Indo U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03) - PA-10-115
What is the Indo U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03)?
The Indo U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03) is an NIH discretionary grant opportunity intended to strengthen and expand vaccine research collaboration between the United States and India through small, focused research projects.
What is the purpose of this grant opportunity?
The purpose is to support joint vaccine-related research that can help reduce the burden of infectious diseases relevant to India, the United States, the South Asian region, and global public health. The program is designed to augment ongoing VAP efforts rather than function as a standalone clinical trial funding stream.
What is the Funding Opportunity Number for this announcement?
The Funding Opportunity Number provided is PA 10-115.
What NIH grant mechanism does this opportunity use?
This opportunity uses the NIH R03 mechanism, which is intended for small, focused research projects.
Does the grant support work in both India and the United States?
Yes. The grant provides U.S. dollar support for vaccine-related research activities carried out in India and the United States, consistent with the program's collaborative U.S.-India focus.
Which diseases or topic areas are specifically encouraged?
Applicants are encouraged to propose vaccine-related projects in dengue, influenza (including avian influenza), HIV/AIDS, and tuberculosis, as long as the work is conducted through well-established collaborations with Indian investigators.
What types of research approaches are within scope for this program?
The scope includes basic research (such as early-stage discovery and immunology), translational work (bridging lab findings toward product-relevant concepts), clinical research that does not involve trials, and epidemiological studies that inform vaccine development or evaluation strategies.
Are clinical trials allowed under this initiative?
No. Clinical trials are explicitly not supported under this initiative. Proposals should avoid clinical trial implementation and instead focus on preparatory, supporting, or non-trial clinical and population research.
Does this program require collaboration with Indian investigators?
Yes. The announcement emphasizes that proposed projects should be conducted through well-established collaborations with Indian investigators.
Who is eligible to apply?
Eligibility is broad and includes many U.S. and non-U.S. entities. The list includes various levels of government (state, county, city, township, special districts), public and state-controlled universities, private institutions of higher education, nonprofit organizations (with or without 501(c)(3) status), public housing authorities and Indian housing authorities, for-profit organizations, independent school districts, tribal governments and tribal organizations, U.S. territories or possessions, and non-domestic (non-U.S.) entities/foreign organizations.
Are specific institution types explicitly mentioned as eligible?
Yes. The eligibility list explicitly mentions Alaska Native and Native Hawaiian Serving Institutions, Historically Black Colleges and Universities (HBCUs), Hispanic Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), as well as faith-based and community-based organizations and regional organizations.
Are small businesses eligible?
Small businesses are explicitly stated as eligible in the description provided.
Is cost sharing or matching required?
No. Cost sharing or matching is not required.
How much funding is available per award, and how many awards will be made?
Funding levels and the anticipated number of awards are not fixed. NIH expects applications to vary by scope, duration, and cost, so the total dollars awarded and the number of grants depend on the quantity and quality of applications received, proposed timelines, and the reasonableness of budgets.
What is the CFDA number associated with this program?
The program is associated with CFDA 93.856 (Microbiology and Infectious Diseases Research).
What category is this funding opportunity listed under?
This opportunity is categorized under Health.
When was this opportunity posted, and what is its current status?
The listing indicates it was posted on February 26, 2010, and later administrative information indicates it ultimately became archived after the final closing window in 2013.
Where can applicants find the full funding announcement?
NIH provided the full announcement link here: http://grants.nih.gov/grants/guide/pa-files/PA-10-115.html
Who should be contacted for technical access issues with the announcement?
Technical access questions were directed to the NIH Office of Extramural Research (OER) webmaster.
What is the historical background of the VAP collaboration?
The program traces back to a formal Memorandum of Understanding signed on July 9, 1987, and was created to build on earlier bilateral science and technology cooperation frameworks, including the Indo-U.S. Science and Technology Subcommission, the Gandhi-Reagan Science and Technology Initiative, the U.S.-India Fund, and the broader Science and Technology Cooperation Agreement.
Browse more opportunities from the same category: Health
Next opportunity: ARRA Equipment to Enhance Training for Health Professionals Comprehensive Geriatric Education Program
Previous opportunity: ARRA Equipment to Enhance Training for Health Professionals Advanced Education Nursing Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 10 115
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 10 115) also looked into and applied for these:
| Funding Opportunity |
|---|
| Support Establishment and Sustainability of Medical Waste Management Systems in the Republic of Kenya under the President s Emergency plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10135 Funding Number: CDC RFA PS10 10135 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $800,000 |
| Production Of Human Proteins To Be Used For Generating Affinity Reagents (U01) Apply for RFA RM 10 007 Funding Number: RFA RM 10 007 Agency: National Institutes of Health Category: Health Funding Amount: $600,000 |
| Providing a Comprehensive Continuum of HIV/AIDS Care and Treatment Services in the Democratic Republic of Congo Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10132 Funding Number: CDC RFA PS10 10132 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| ARRA Equipment to Enhance Training for Health Professionals Preventive Medicine Residency Program Apply for HRSA 10 180 Funding Number: HRSA 10 180 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Large Scale Production of Perturbagen Induced Cellular Signatures (U54) Apply for RFA RM 10 003 Funding Number: RFA RM 10 003 Agency: National Institutes of Health Category: Health Funding Amount: $900,000 |
| DEPARTMENT OF DEFENSE HIV/AIDS PREVENTION PROGRAM Apply for DHAPPBAA10 001 Funding Number: DHAPPBAA10 001 Agency: Naval Supply Systems Command Category: Health Funding Amount: Case Dependent |
| APHIAplus PROGRAM DESCRIPTION Apply for RFA 623 10 000009 Funding Number: RFA 623 10 000009 Agency: Kenya USAID Nairobi Category: Health Funding Amount: $76,000,000 |
| MCH Research Network on Pregnancy Related Care Apply for HRSA 10 088 Funding Number: HRSA 10 088 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia during the Influenza Season (U18) Apply for RFA IP 10 007 Funding Number: RFA IP 10 007 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Maintaining Collection of National Violent Death Reporting System (NVDRS) Data, NCIPC Apply for CE08 80203CONT10 Funding Number: CE08 80203CONT10 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Maintaining Collection of National Violent Death Reporting System (NVDRS) Data, NCIPC Apply for CE07 70404CONT10 Funding Number: CE07 70404CONT10 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Development of the National Violent Death Reporting System (NVDRS), NCIPC Apply for CE09 90402CONT10 Funding Number: CE09 90402CONT10 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Promoting Extensive Implementation of Quality Prevention of Mother to Child Transmission (PMTCT) Activities in the Republic of Uganda Apply for CDC RFA PS04 230 Funding Number: CDC RFA PS04 230 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Strengthening Public Health Capacity and Strategic Information Systems through Cooperation with the Joint United Nations Programme on HIV/AIDS (UNAIDS) under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10157 Funding Number: CDC RFA PS10 10157 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Providing Capacity Building Assistance to Governmental and Indigenous Organizations in order to Improve the Delivery of HIV/AIDS Services in the Democratic Republic of Congo Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10101 Funding Number: CDC RFA PS10 10101 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Family Centered Substance Abuse Treatment Grants for Adolescents and their Families Apply for TI 10 002 Funding Number: TI 10 002 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $300,000 |
| Improving availability of safe blood transfusion services through a mentoring technical assistance (TA) relationship with The Nigerian National Blood Transfusion Service, to ensure a sustainable quality management system in the Federal Republic of Ni Apply for CDC RFA PS10 1039 Funding Number: CDC RFA PS10 1039 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Strengthening the Capacity of the Republican AIDS Center to implement HIV Programs in the Kyrgyz Republic under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10163 Funding Number: CDC RFA PS10 10163 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Strengthening the Capacity of the Republican AIDS Center to Implement HIV Programs in the Republic of Kazakhstan under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10164 Funding Number: CDC RFA PS10 10164 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| New Approaches to Arrhythmia Detection and Treatment (SBIR R43/R44) Apply for PA 10 117 Funding Number: PA 10 117 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 10 115", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.